Regal Rexnord Valuation
Is RRX * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of RRX * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: RRX * (MX$3025) is trading below our estimate of fair value (MX$4066.18)
Significantly Below Fair Value: RRX * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for RRX *?
Other financial metrics that can be useful for relative valuation.
What is RRX *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$11.04b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 2.6x |
Enterprise Value/EBITDA | 13.3x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does RRX *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 2.9x | ||
GCARSO A1 Grupo Carso. de | 1.4x | 6.0% | Mex$274.9b |
IDEAL B-1 Impulsora del Desarrollo y el Empleo en América Latina. de | 3.9x | n/a | Mex$110.6b |
ALFA A Alfa. de | 0.3x | 6.5% | Mex$75.1b |
POLYCAB Polycab India | 5.8x | 15.0% | ₹1.1t |
RRX * Regal Rexnord | 1.7x | 1.8% | Mex$11.0b |
Price-To-Sales vs Peers: RRX * is good value based on its Price-To-Sales Ratio (1.7x) compared to the peer average (2.8x).
Price to Earnings Ratio vs Industry
How does RRX *'s PE Ratio compare vs other companies in the Global Electrical Industry?
Price-To-Sales vs Industry: RRX * is expensive based on its Price-To-Sales Ratio (1.7x) compared to the Global Electrical industry average (1.7x).
Price to Sales Ratio vs Fair Ratio
What is RRX *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 1.7x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate RRX *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | n/a | Mex$3,815.08 0% | 5.5% | Mex$4,132.80 | Mex$3,492.50 | n/a | 8 |
Sep ’25 | n/a | Mex$3,714.64 0% | 5.5% | Mex$4,047.15 | Mex$3,420.13 | n/a | 8 |
Aug ’25 | n/a | Mex$3,630.05 0% | 6.4% | Mex$3,998.46 | Mex$3,303.89 | n/a | 8 |
Jul ’25 | n/a | Mex$3,550.26 0% | 8.2% | Mex$3,856.71 | Mex$3,026.97 | n/a | 9 |
Jun ’25 | Mex$2,478.00 | Mex$3,300.37 +33.2% | 7.9% | Mex$3,548.54 | Mex$2,785.10 | n/a | 9 |
May ’25 | n/a | Mex$3,249.18 0% | 8.6% | Mex$3,514.14 | Mex$2,745.03 | n/a | 9 |
Apr ’25 | n/a | Mex$3,188.04 0% | 7.9% | Mex$3,519.87 | Mex$2,762.60 | n/a | 9 |
Mar ’25 | n/a | Mex$3,088.86 0% | 5.3% | Mex$3,375.21 | Mex$2,809.60 | n/a | 9 |
Feb ’25 | n/a | Mex$2,847.07 0% | 6.2% | Mex$3,044.75 | Mex$2,452.72 | n/a | 9 |
Jan ’25 | Mex$2,517.00 | Mex$2,767.71 +10.0% | 7.0% | Mex$3,006.05 | Mex$2,490.72 | n/a | 8 |
Dec ’24 | n/a | Mex$2,778.03 0% | 6.8% | Mex$3,029.01 | Mex$2,509.75 | n/a | 6 |
Nov ’24 | n/a | Mex$3,313.09 0% | 9.7% | Mex$3,562.46 | Mex$2,636.22 | n/a | 6 |
Oct ’24 | n/a | Mex$3,410.85 0% | 4.8% | Mex$3,671.89 | Mex$3,202.02 | n/a | 6 |
Sep ’24 | n/a | Mex$3,388.82 0% | 5.1% | Mex$3,617.41 | Mex$3,154.51 | n/a | 6 |
Aug ’24 | n/a | Mex$3,189.60 0% | 5.4% | Mex$3,557.73 | Mex$3,035.03 | n/a | 6 |
Jul ’24 | n/a | Mex$3,387.60 0% | 1.6% | Mex$3,485.44 | Mex$3,301.99 | n/a | 6 |
Jun ’24 | n/a | Mex$3,387.60 0% | 1.6% | Mex$3,485.44 | Mex$3,301.99 | Mex$2,478.00 | 6 |
May ’24 | n/a | Mex$3,387.60 0% | 1.6% | Mex$3,485.44 | Mex$3,301.99 | n/a | 6 |
Apr ’24 | n/a | Mex$3,387.60 0% | 1.6% | Mex$3,485.44 | Mex$3,301.99 | n/a | 6 |
Mar ’24 | n/a | Mex$3,500.98 0% | 1.7% | Mex$3,589.14 | Mex$3,400.24 | n/a | 6 |
Feb ’24 | Mex$2,606.00 | Mex$3,132.42 +20.2% | 10.4% | Mex$3,535.02 | Mex$2,553.07 | n/a | 6 |
Jan ’24 | n/a | Mex$3,132.42 0% | 10.4% | Mex$3,535.02 | Mex$2,553.07 | Mex$2,517.00 | 6 |
Dec ’23 | n/a | Mex$3,096.84 0% | 12.1% | Mex$3,697.05 | Mex$2,490.24 | n/a | 6 |
Nov ’23 | n/a | Mex$3,400.27 0% | 7.0% | Mex$3,805.94 | Mex$3,096.02 | n/a | 7 |
Oct ’23 | n/a | Mex$3,486.53 0% | 7.3% | Mex$3,875.59 | Mex$3,152.69 | n/a | 8 |
Analyst Forecast: Target price is less than 20% higher than the current share price.